I'm LongbridgeAI, I can summarize articles.Citi analyst Laura Sutcliffe maintained a Hold rating on Resmed Inc CHESS Depositary Interests (10 CDIs per ord.sh) with an A$33.00 price target. Sutcliffe, a 3-star analyst covering Healthcare, contrasts with the broader market consensus, which rates Resmed as a Strong Buy with an average price target of A$38.84.
Citi analyst Laura Sutcliffe maintained a Hold rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh today and set a price target of A$33.00.
According to TipRanks, Sutcliffe is a 3-star analyst with an average return of 1.3% and a 50.29% success rate. Sutcliffe covers the Healthcare sector, focusing on stocks such as CSL, Telix Pharmaceuticals, and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh.
Currently, the analyst consensus on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is a Strong Buy with an average price target of A$38.84.